Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 28039172.
- Also identified by DOI 10.2337/dc16-1769.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To define the threshold for excess glucose variability (GV), one of the main features of dysglycemia in diabetes. A total of 376 persons with diabetes investigated at the University Hospital of Montpellier (Montpellier, France) underwent continuous glucose monitoring. Participants with type 2 diabetes were divided into several groups-groups 1, 2a, 2b, and 3 (<i>n</i> = 82, 28, 65, and 79, respectively)-according to treatment: <i>1</i>) diet and/or insulin sensitizers alone; <i>2</i>) oral therapy including an insulinotropic agent, dipeptidyl peptidase 4 inhibitors (group 2a) or sulfonylureas (group 2b); or <i>3</i>) insulin. Group 4 included 122 persons with type 1 diabetes. Percentage coefficient of variation for glucose (%CV = [(SD of glucose)/(mean glucose)] × 100) and frequencies of hypoglycemia (interstitial glucose <56 mg/dL [3.1 mmol/L]) were computed. Percentages of CV (median [interquartile range]; %) increased significantly (<i>P</i> < 0.0001) from group 1 (18.1 [15.2-23.9]) to group 4 (37.2 [31.0-42.3]). In group 1, the upper limit of %CV, which served as reference for defining excess GV, was 36%. Percentages of patients with %CVs above this threshold in groups 2a, 2b, 3, and 4 were 0, 12.3, 19.0, and 55.7%, respectively. Hypoglycemia was more frequent in group 2b (<i>P</i> < 0.01) and groups 3 and 4 (<i>P</i> < 0.0001) when subjects with a %CV >36% were compared with those with %CV ≤36%. A %CV of 36% appears to be a suitable threshold to distinguish between stable and unstable glycemia in diabetes because beyond this limit, the frequency of hypoglycemia is significantly increased, especially in insulin-treated subjects.
Medical subject headings
- Blood Glucose
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Hypoglycemic Agents
- Sulfonylurea Compounds